NO944749L - Nye steroider med pregnanskjelett, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremtilling av disse - Google Patents
Nye steroider med pregnanskjelett, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremtilling av disseInfo
- Publication number
- NO944749L NO944749L NO944749A NO944749A NO944749L NO 944749 L NO944749 L NO 944749L NO 944749 A NO944749 A NO 944749A NO 944749 A NO944749 A NO 944749A NO 944749 L NO944749 L NO 944749L
- Authority
- NO
- Norway
- Prior art keywords
- amino group
- heterocyclic secondary
- secondary amino
- alkyl
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9201910A HU212308B (en) | 1992-06-09 | 1992-06-09 | Process for producing novel pregnane steroids and pharmaceutical compositions containing the same |
PCT/HU1993/000035 WO1993025570A1 (en) | 1992-06-09 | 1993-06-08 | Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same |
Publications (2)
Publication Number | Publication Date |
---|---|
NO944749D0 NO944749D0 (no) | 1994-12-08 |
NO944749L true NO944749L (no) | 1995-02-08 |
Family
ID=10982020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944749A NO944749L (no) | 1992-06-09 | 1994-12-08 | Nye steroider med pregnanskjelett, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremtilling av disse |
Country Status (17)
Country | Link |
---|---|
US (1) | US5547949A (sv) |
EP (1) | EP0646126A1 (sv) |
JP (1) | JPH07507792A (sv) |
KR (1) | KR950701933A (sv) |
AU (1) | AU4352393A (sv) |
CA (1) | CA2136546A1 (sv) |
CZ (1) | CZ308094A3 (sv) |
EE (1) | EE9400071A (sv) |
FI (1) | FI945781A (sv) |
HR (1) | HRP930956A2 (sv) |
HU (1) | HU212308B (sv) |
IL (1) | IL105943A0 (sv) |
NO (1) | NO944749L (sv) |
RU (1) | RU94046369A (sv) |
SI (1) | SI9300311A (sv) |
WO (1) | WO1993025570A1 (sv) |
ZA (1) | ZA934036B (sv) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1079859B1 (en) | 1998-05-22 | 2010-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
US7081470B2 (en) * | 2001-01-31 | 2006-07-25 | H. Lundbeck A/S | Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
US20040127502A1 (en) * | 2001-01-31 | 2004-07-01 | Synaptic Pharmaceutical Corporation | Use of GAL3 antagonist for treatment of depression |
MY141867A (en) * | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
NL2000323C2 (nl) * | 2005-12-20 | 2007-11-20 | Pfizer Ltd | Pyrimidine-derivaten. |
DK2444092T3 (en) | 2008-05-28 | 2015-09-28 | Reveragen Biopharma Inc | Non-hormonal steroidmodulatorer of NF-? B for the treatment of disease |
DK2398500T3 (da) | 2009-02-20 | 2019-05-13 | 2 Bbb Medicines B V | Glutathion-baseret lægemiddelafgivelsessystem |
IL255113B (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them |
WO2011127048A2 (en) | 2010-04-05 | 2011-10-13 | Validus Biopharma | NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5099019A (en) * | 1985-09-12 | 1992-03-24 | Upjohn Company | Amines useful in producing pharmaceutically active CNS compounds |
ES2078890T3 (es) * | 1986-10-09 | 1996-01-01 | Upjohn Co | Amino esteroides en c20 a c26. |
FR2644787B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
FR2644789B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
CA2071000A1 (en) * | 1990-01-26 | 1991-07-27 | John M. Mccall | 5-oxygenated-2,4,6-triaminopyrimidines |
-
1992
- 1992-06-09 HU HU9201910A patent/HU212308B/hu not_active IP Right Cessation
-
1993
- 1993-06-08 ZA ZA934036A patent/ZA934036B/xx unknown
- 1993-06-08 IL IL105943A patent/IL105943A0/xx unknown
- 1993-06-08 EP EP93913455A patent/EP0646126A1/en not_active Withdrawn
- 1993-06-08 CA CA002136546A patent/CA2136546A1/en not_active Abandoned
- 1993-06-08 AU AU43523/93A patent/AU4352393A/en not_active Abandoned
- 1993-06-08 HR HRP930956AA patent/HRP930956A2/hr not_active Application Discontinuation
- 1993-06-08 CZ CZ943080A patent/CZ308094A3/cs unknown
- 1993-06-08 KR KR1019940704496A patent/KR950701933A/ko not_active Application Discontinuation
- 1993-06-08 JP JP6501316A patent/JPH07507792A/ja active Pending
- 1993-06-08 WO PCT/HU1993/000035 patent/WO1993025570A1/en not_active Application Discontinuation
- 1993-06-08 US US08/351,448 patent/US5547949A/en not_active Expired - Fee Related
- 1993-06-09 SI SI9300311A patent/SI9300311A/sl unknown
-
1994
- 1994-06-29 EE EE9400071A patent/EE9400071A/xx unknown
- 1994-12-06 RU RU94046369/04A patent/RU94046369A/ru unknown
- 1994-12-08 NO NO944749A patent/NO944749L/no unknown
- 1994-12-08 FI FI945781A patent/FI945781A/sv not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR950701933A (ko) | 1995-05-17 |
HU212308B (en) | 1996-05-28 |
IL105943A0 (en) | 1993-10-20 |
NO944749D0 (no) | 1994-12-08 |
US5547949A (en) | 1996-08-20 |
CZ308094A3 (en) | 1995-11-15 |
WO1993025570A1 (en) | 1993-12-23 |
HUT64562A (en) | 1994-01-28 |
RU94046369A (ru) | 1996-09-27 |
ZA934036B (en) | 1994-01-06 |
CA2136546A1 (en) | 1993-12-23 |
SI9300311A (sl) | 1993-12-31 |
AU4352393A (en) | 1994-01-04 |
EP0646126A1 (en) | 1995-04-05 |
EE9400071A (et) | 1995-12-15 |
JPH07507792A (ja) | 1995-08-31 |
HU9201910D0 (en) | 1992-09-28 |
FI945781A0 (sv) | 1994-12-08 |
HRP930956A2 (hr) | 1995-02-28 |
FI945781A (sv) | 1994-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO944749L (no) | Nye steroider med pregnanskjelett, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremtilling av disse | |
ATE33838T1 (de) | Thiazolidinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
DE3271269D1 (en) | Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
NO153455C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte imidazolderivater. | |
NO824062L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
DE2965292D1 (en) | Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
FI834800A0 (fi) | Foerfarande foer framstaellning av dialkylaminoalkoxibensylalkohol-derivat | |
ES8403125A1 (es) | Procedimiento para la preparacion de nuevas piridobenzodiazepinonas. | |
ES8701174A1 (es) | Un metodo de preparacion de un compuesto de tiadiazina | |
GB1421446A (en) | Disalkylamino esters of benzopyranopyridines and compositions containing the same | |
ZA857676B (en) | 2-pyridine-thiol derivatives,process for their preparation and pharmaceutical compositions containing them | |
KR890701584A (ko) | 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물 | |
LTIP600A (lt) | Nauji pregnano skeletą turintys steroidai, farmacinė kompozicija ir jų gavimo būdas | |
NO944748L (no) | Nye biologiske aktive eburnameninderivater, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremstilling av disse | |
GB875023A (en) | New succinimides and process for their manufacture |